PortalPublikationenLong-term treatment with deferiprone in a L1 veteran.

Long-term treatment with deferiprone in a L1 veteran.

Standard

Long-term treatment with deferiprone in a L1 veteran. / Meo, Anna; Ruggeri, Annalisa; Rosa, La; Angela, Maria; Kordes, Uwe; Kordes, Uwe; Fischer, Roland.

in: EUR J HAEMATOL, Jahrgang 74, Nr. 6, 6, 2005, S. 523-525.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Meo, A, Ruggeri, A, Rosa, L, Angela, M, Kordes, U, Kordes, U & Fischer, R 2005, 'Long-term treatment with deferiprone in a L1 veteran.', EUR J HAEMATOL, Jg. 74, Nr. 6, 6, S. 523-525. <http://www.ncbi.nlm.nih.gov/pubmed/15876257?dopt=Citation>

APA

Meo, A., Ruggeri, A., Rosa, L., Angela, M., Kordes, U., Kordes, U., & Fischer, R. (2005). Long-term treatment with deferiprone in a L1 veteran. EUR J HAEMATOL, 74(6), 523-525. [6]. http://www.ncbi.nlm.nih.gov/pubmed/15876257?dopt=Citation

Vancouver

Meo A, Ruggeri A, Rosa L, Angela M, Kordes U, Kordes U et al. Long-term treatment with deferiprone in a L1 veteran. EUR J HAEMATOL. 2005;74(6):523-525. 6.

Bibtex

@article{c7701779eba2449988d72140bd17e3fc,
title = "Long-term treatment with deferiprone in a L1 veteran.",
abstract = "We studied a patient with mild beta-thalassaemia major under treatment with the oral chelator deferiprone (DFP or L1) for about 10 yr (L1 veteran). Due to poor compliance with desferrioxamine, the patient started compassionate use of DFP at an age of 23 yr with a serum ferritin of 5200 microg/L. Monitoring iron overload by SQUID biosusceptometry revealed a dramatic decrease of liver iron concentrations from 4500 to 950 microg/g(liver) within 9.5 yr. A good clinical response to chelation treatment with DFP was observed together with an improvement of liver and cardiac function and a reduction in the hepatitis virus load.",
author = "Anna Meo and Annalisa Ruggeri and La Rosa and Maria Angela and Uwe Kordes and Uwe Kordes and Roland Fischer",
year = "2005",
language = "Deutsch",
volume = "74",
pages = "523--525",
journal = "EUR J HAEMATOL",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - Long-term treatment with deferiprone in a L1 veteran.

AU - Meo, Anna

AU - Ruggeri, Annalisa

AU - Rosa, La

AU - Angela, Maria

AU - Kordes, Uwe

AU - Kordes, Uwe

AU - Fischer, Roland

PY - 2005

Y1 - 2005

N2 - We studied a patient with mild beta-thalassaemia major under treatment with the oral chelator deferiprone (DFP or L1) for about 10 yr (L1 veteran). Due to poor compliance with desferrioxamine, the patient started compassionate use of DFP at an age of 23 yr with a serum ferritin of 5200 microg/L. Monitoring iron overload by SQUID biosusceptometry revealed a dramatic decrease of liver iron concentrations from 4500 to 950 microg/g(liver) within 9.5 yr. A good clinical response to chelation treatment with DFP was observed together with an improvement of liver and cardiac function and a reduction in the hepatitis virus load.

AB - We studied a patient with mild beta-thalassaemia major under treatment with the oral chelator deferiprone (DFP or L1) for about 10 yr (L1 veteran). Due to poor compliance with desferrioxamine, the patient started compassionate use of DFP at an age of 23 yr with a serum ferritin of 5200 microg/L. Monitoring iron overload by SQUID biosusceptometry revealed a dramatic decrease of liver iron concentrations from 4500 to 950 microg/g(liver) within 9.5 yr. A good clinical response to chelation treatment with DFP was observed together with an improvement of liver and cardiac function and a reduction in the hepatitis virus load.

M3 - SCORING: Zeitschriftenaufsatz

VL - 74

SP - 523

EP - 525

JO - EUR J HAEMATOL

JF - EUR J HAEMATOL

SN - 0902-4441

IS - 6

M1 - 6

ER -